Your browser doesn't support javascript.
loading
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara A; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Villanueva Vazquez, Rafael; Jung, Kyung Hae; Babu, K Govind; Wheatley-Price, Paul; De Laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Carlson, Gary; Hughes, Gareth; Diaz-Padilla, Ivan; Germa, Caroline; Hirawat, Samit; Lu, Yen-Shen.
Afiliação
  • Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Im SA; Seoul National University Hospital, Cancer Research Institute, and Seoul National University College of Medicine, Seoul, South Korea.
  • Colleoni M; Division of Medical Senology, Istituto Europeo di Oncologia, Milan, Italy.
  • Franke F; Hospital de Caridade de Ijuí, Cacon, Ijuí, Brazil.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Harbeck N; Breast Center, Department of Obstetrics and Gynaecology, University of Munich, Munich, Germany.
  • Hurvitz SA; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Chow L; Organisation for Oncology and Translational Research, Hong Kong Special Administrative Region, China.
  • Sohn J; Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea.
  • Lee KS; Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
  • Campos-Gomez S; Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico.
  • Villanueva Vazquez R; Institut Català d'Oncologia, Hospital Moisès Broggi, Barcelona, Spain.
  • Jung KH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Babu KG; HCG Curie Centre of Oncology and Kidwai Memorial Institute of Oncology, Bangalore, India.
  • Wheatley-Price P; University of Ottawa, Ottawa, ON, Canada.
  • De Laurentiis M; Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy.
  • Im YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Kuemmel S; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
  • El-Saghir N; American University of Beirut Medical Center, Beirut, Lebanon.
  • Liu MC; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.
  • Carlson G; Novartis, East Hanover, NJ, USA.
  • Hughes G; Novartis, Basel, Switzerland.
  • Diaz-Padilla I; Novartis, Basel, Switzerland.
  • Germa C; Novartis, East Hanover, NJ, USA.
  • Hirawat S; Novartis, East Hanover, NJ, USA.
  • Lu YS; National Taiwan University Hospital, Taipei, Taiwan. Electronic address: yslu@ntu.edu.tw.
Lancet Oncol ; 19(7): 904-915, 2018 07.
Article em En | MEDLINE | ID: mdl-29804902

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Saude_da_mulher / Mama / Tipos_de_cancer / Mama / Outros_tipos Base de dados: MEDLINE Assunto principal: Purinas / Neoplasias da Mama / Antineoplásicos Hormonais / Aminopiridinas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Saude_da_mulher / Mama / Tipos_de_cancer / Mama / Outros_tipos Base de dados: MEDLINE Assunto principal: Purinas / Neoplasias da Mama / Antineoplásicos Hormonais / Aminopiridinas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos